Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXO-001 in women undergoing donor oocyte IVF/ICSI with fresh single blastocyst transfer
2021-000001-25Phase 2Completed
- Sponsor
- Oxolife
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium tungstate in infertility (3 arms), sponsored by Oxolife. Primary endpoint: Ongoing pregnancy rate at 10 weeks post embryo transfer. Started May 2021; status: completed.
02
Drugs
sodium tungstate
03
Conditions
infertility
Beyond the preview
Go deeper on 2021-000001-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-000001-25.